Cipralex / Lexapro - Tolerability in MDD

Escitalopram Therapy for Major Depression and Anxiety Disorders

Baldwin et al. Ann Pharmacotherapy 2007;41: 1583-1592

Discontinuation symptoms in depression and anxiety disorders

David S. Baldwin, Stuart A. Montgomery, Rico Nil and Malcolm Lader, Int J Neuropsychopharmacology 2005; 9: 1-12

A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder

Bielski et al., Journal of Clinical Psychiatry 2004; 65: 1190-1196

A Double-blind Comparison of Escitalopram and Paroxetine in the Treatment of Generalized Anxiety Disorder

Bielski et al., Annals of Clinical Psychiatry 2005 17:65-69

Prevention of relapse in older patients with major depressive disorder by Escitalopram treatment

Gorwood P, Weiller E, Lemming O and Katona C, Hôpital Louis Mourier, Colombes, France; H. Lundbeck A/S, Copenhagen, Denmark; Kent Institute of Medicine & Health Sciences, University of Kent, UK

A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder

Montgomery et al., Neuropsychobiology 2004;50:57-64

Escitalopram continuation treatment prevents relapse of depressive episodes

Rapaport et al., Journal of Clinical Psychiatry 2004;65:44-49

Managing depressive and anxiety disorders with escitalopram

Thase, M. Expert Opin Pharmacother 2006; 7: 429-440

Escitalopram in the long-term treatment of major depressive disorder.

Wade et al., Ann Clin Psychiatry. 2006 Apr-Jun;18(2):83-9

Tolerability within depression